World

Israeli missiles strike Gaza hospital

Apr 14, 2025

Jerusalem [Israel], April 14: Two Israeli missiles hit a major Gaza hospital on Sunday, putting the emergency department out of action and damaging other structures, medics said, in a strike which Israel said was aimed at Hamas fighters exploiting the facility.
Health officials at the Al-Ahli Arab Hospital evacuated patients after a phone call from someone who identified himself as Israeli security shortly before the attack.
No casualties were reported in the strike. The Israeli military said in a statement that it had taken steps to reduce harm to civilians before it struck the compound, which it said was being used by Hamas militants to plan attacks. Hamas rejected the accusation and called for an international investigation.
The hospital - an institution run by the Anglican Church in Jerusalem - was no longer operational, according to Gaza's health ministry.
"Hundreds of patients and injured people had to be evacuated in the middle of the night, and many of them are now out in the streets without medical care, which puts their lives at risk," said ministry spokesperson Khalil Al-Deqran.
Sunday's strikes came as Hamas leaders began a fresh round of talks in Cairo in a bid to salvage a stalled ceasefire agreement with Israel, as Egypt, Qatar, and the United States attempted to bridge gaps between the sides.
Reuters footage showed significant destruction in and outside the hospital compound's church, and patients who could not leave.
Source: Fijian Broadcasting Corporation

More news

Infosys: Differentiated AI strategy and a sharp focus on value unlock propels 29% sequential growth in AI revenues

Bengaluru (Karnataka) [India], October 23: Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in AI-first business consulting and technology services, delivered $5,145 million in Q2 revenues, year on year growth of 1.5% and sequential growth of 1.2% in constant currency. Operating margin was stable at 21.0%. EPS growth was 8.7% year on year in rupee terms. TCV of large deal wins was $5.2 billion, with 62% net new. Robust Q2 large deal TCV at $5.2 billion with 62% net new; lays solid foundation for future growth. FY 27 revenue guidance revised to 1%-2% and margin guidance retained at 20%-22%.

Oct 23, 2026